Christine J. Saoud

Array ( [id] => 307442 [patent_doc_number] => 07531508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Splice variant of the human pituitary growth hormone' [patent_app_type] => utility [patent_app_number] => 10/537142 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24029 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531508.pdf [firstpage_image] =>[orig_patent_app_number] => 10537142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675266 [patent_doc_number] => 20040126852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity' [patent_app_type] => new [patent_app_number] => 10/715795 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38190 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126852.pdf [firstpage_image] =>[orig_patent_app_number] => 10715795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 390324 [patent_doc_number] => 07300920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-27 [patent_title] => 'Antiangiogenic peptide agents' [patent_app_type] => utility [patent_app_number] => 10/714067 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 21157 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/300/07300920.pdf [firstpage_image] =>[orig_patent_app_number] => 10714067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405193 [patent_doc_number] => 20040175730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Vascular endothelial growth factor D(VEGF-D) antibodies and vectors, and methods of use' [patent_app_type] => new [patent_app_number] => 10/705476 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16135 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175730.pdf [firstpage_image] =>[orig_patent_app_number] => 10705476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7286807 [patent_doc_number] => 20040146908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders' [patent_app_type] => new [patent_app_number] => 10/712560 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 42678 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146908.pdf [firstpage_image] =>[orig_patent_app_number] => 10712560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 569052 [patent_doc_number] => 07462593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Compositions and methods for promoting angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/529116 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22870 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462593.pdf [firstpage_image] =>[orig_patent_app_number] => 10529116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033661 [patent_doc_number] => 20050032171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine' [patent_app_type] => utility [patent_app_number] => 10/690658 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18239 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032171.pdf [firstpage_image] =>[orig_patent_app_number] => 10690658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662084 [patent_doc_number] => 20060252680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone' [patent_app_type] => utility [patent_app_number] => 10/532740 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21001 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252680.pdf [firstpage_image] =>[orig_patent_app_number] => 10532740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275639 [patent_doc_number] => 20040235090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Process for preparing a desired protein' [patent_app_type] => new [patent_app_number] => 10/689445 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4049 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235090.pdf [firstpage_image] =>[orig_patent_app_number] => 10689445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434498 [patent_doc_number] => 20040162419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides' [patent_app_type] => new [patent_app_number] => 10/311830 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46037 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162419.pdf [firstpage_image] =>[orig_patent_app_number] => 10311830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7352244 [patent_doc_number] => 20040048341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Vascular endothelial growth factor (VEGF) molecule and process for producing same' [patent_app_type] => new [patent_app_number] => 10/673708 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 9627 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048341.pdf [firstpage_image] =>[orig_patent_app_number] => 10673708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632221 [patent_doc_number] => 20060148691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Sustained release preparation for therapy of coronary stenosis or obstruction' [patent_app_type] => utility [patent_app_number] => 10/528998 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5381 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148691.pdf [firstpage_image] =>[orig_patent_app_number] => 10528998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166484 [patent_doc_number] => 20040077011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Novel human gene relating to respiratory diseases and obesity' [patent_app_type] => new [patent_app_number] => 10/670184 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 34557 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077011.pdf [firstpage_image] =>[orig_patent_app_number] => 10670184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439465 [patent_doc_number] => 07259144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Methods for diagnosing and treatment of hyperphosphatemic conditions using FGF20 polypeptides' [patent_app_type] => utility [patent_app_number] => 10/644349 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6394 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259144.pdf [firstpage_image] =>[orig_patent_app_number] => 10644349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674708 [patent_doc_number] => 20040127410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Circular permuteins of flt3 ligand' [patent_app_type] => new [patent_app_number] => 10/644355 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17984 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127410.pdf [firstpage_image] =>[orig_patent_app_number] => 10644355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5830889 [patent_doc_number] => 20060064767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy' [patent_app_type] => utility [patent_app_number] => 10/524823 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13704 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20060064767.pdf [firstpage_image] =>[orig_patent_app_number] => 10524823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7388939 [patent_doc_number] => 20040030115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => '31 human secreted proteins' [patent_app_type] => new [patent_app_number] => 10/633680 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84540 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030115.pdf [firstpage_image] =>[orig_patent_app_number] => 10633680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7293582 [patent_doc_number] => 20040111667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Human CCN-like growth factor' [patent_app_type] => new [patent_app_number] => 10/627604 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7337 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20040111667.pdf [firstpage_image] =>[orig_patent_app_number] => 10627604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7293582 [patent_doc_number] => 20040111667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Human CCN-like growth factor' [patent_app_type] => new [patent_app_number] => 10/627604 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7337 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20040111667.pdf [firstpage_image] =>[orig_patent_app_number] => 10627604 [rel_patent_id] =>[rel_patent_doc_number] =>)